MedPath

TandemHeart to Reduce Infarct Size (TRIS Trial)

Not Applicable
Withdrawn
Conditions
Acute Myocardial Infarction
Interventions
Device: TandemHeart System
Procedure: Percutaneous coronary intervention
Registration Number
NCT02164058
Lead Sponsor
CardiacAssist, Inc.
Brief Summary

The purpose of this study is to determine if a device known as the TandemHeart® System (TandemHeart) can help limit heart damage and reduce serious complications after a certain type of heart attack (acute ST elevation anterior wall myocardial infarction \[STEMI\]) by evaluating the use of the TandemHeart system prior to a procedure called percutaneous coronary intervention (PCI)

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TandemHeart System + PCIPercutaneous coronary interventionTandemHeart System prior to percutaneous coronary intervention
PCIPercutaneous coronary interventionPercutaneous coronary intervention
TandemHeart System + PCITandemHeart SystemTandemHeart System prior to percutaneous coronary intervention
Primary Outcome Measures
NameTimeMethod
Primary Safety30 days post-procedure

Major Adverse Cardiac or Cerebrovascular Events (MACCE):

* Death, all cause

* Stroke

* Reinfarction

* Major vascular complications

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath